AORT News and Press, Artivion Inc Com From 09/03/25

2025-09-03 07:47:55 ET I can’t complain about the performance of Artivion ’s ( AORT ) share price since my last update. Even in an environment that hasn’t been particularly supportive for med-tech, shares of this small cap cardiology med-tech have risen near...

2025-08-08 14:31:41 ET More on Artivion Artivion, Inc. (AORT) Q2 2025 Earnings Call Transcript Artivion Non-GAAP EPS of $0.24 beats by $0.11, revenue of $113M beats by $5.05M Artivion enter $95M exchange agreement Seeking Alpha’s Quant Rating on Artivi...

2025-08-08 14:30:46 ET Artivion, Inc. (AORT) Q2 2025 Earnings Conference Call August 07, 2025, 04:30 PM ET Company Participants Lance A. Berry - Executive VP of Finance & CFO Pat MacKin - Corporate Participant Conference Call Participants Daniel Walke...

A look at the top 10 most actives in the United States Oriental Rise Holdings Limited (ORIS) rose 81.2% to $0.1633 on volume of 563,997,096 shares Safe & Green Holdings Corp. (SGBX) rose 37.3% to $0.3953 on volume of 157,762,055 shares Incannex Healthcare Inc. (IXHL) rose 6.4% to $0.492...

2025-08-07 16:43:49 ET More on Artivion Artivion enter $95M exchange agreement Seeking Alpha’s Quant Rating on Artivion Historical earnings data for Artivion Financial information for Artivion Read the full article on Seeking Alpha For ...

Artivion Reports Second Quarter 2025 Financial Results PR Newswire Second Quarter Highlights: Achieved revenue of $113.0 million in the second quarter of 2025 versus $98.0 million in the second quarter of 2024, an increase of 15% on a GAAP basis and 14% on a no...

Leatt Corp (LEAT) is expected to report for Q2 2025 MDU Resources Group Inc. (Holding Company) (MDU) is expected to report $0.13 for Q2 2025 Video Display Corp. (VIDE) is expected to report for quarter end 2025-05-31 Alarm.com Holdings Inc. (ALRM) is expected to report $0.38 for Q2 20...

Artivion Inc Com (AORT) is expected to report $0.11 for Q2 2025

Artivion to Participate in Upcoming Investor Conferences PR Newswire ATLANTA , July 30, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two...

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results PR Newswire ATLANTA , July 24, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease...